Masatoshi Iida

Title: Inventor Spotlight: Masatoshi Iida

Introduction

Masatoshi Iida, a prominent inventor based in Osaka, Japan, has significantly contributed to the field of pharmaceuticals with his innovative research and patented inventions. With a total of two patents to his name, Iida has made strides in cancer treatment and heterocyclic compounds.

Latest Patents

Iida's recent patents showcase his dedication to advancing medical treatments. His first patent is for a compound known as 5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative, which provides an agent for treating malignant tumors. This innovative compound holds promise for the development of effective therapeutic agents in oncology. His second patent revolves around a heterocyclic compound represented by General Formula (1), along with its pharmaceutical composition, which may lead to novel drug formulations and applications in various medical fields.

Career Highlights

Masatoshi Iida is affiliated with Otsuka Pharmaceutical Company, Limited, where he leverages his expertise in pharmaceutical sciences to drive innovation. His work is pivotal in the development of new treatment modalities that address critical health issues.

Collaborations

Iida collaborates with talented individuals such as Takahiro Katoh and Yuki Terauchi. Together, they contribute to the ongoing research and development efforts at Otsuka Pharmaceutical, pushing the boundaries of what is possible in medicine.

Conclusion

Masatoshi Iida's commitment to innovation in pharmaceuticals is evident through his patents and collaborative efforts. As he continues to work at Otsuka Pharmaceutical Company, Limited, his research may lead to breakthroughs that improve patient care and treatment outcomes for various diseases.